|
Categorization
|
n
|
% analyzable
|
|---|
|
Controls:
|
51
| |
|
Age (median 69)
|
|
≤ 69 years
|
28
|
54.9
|
|
> 69 years
|
23
|
45.1
|
|
Gender
|
|
Male
|
48
|
94.1
|
|
Female
|
3
|
5.9
|
|
Diagnosis
|
|
Disease-free
|
3
|
5.9
|
|
Cystitis
|
5
|
9.8
|
|
Benign prostatic hyperplasia
|
13
|
25.5
|
|
Prostate cancer
|
21
|
41.2
|
|
Testicular tumor
|
6
|
11.8
|
|
Other
|
3
|
5.9
|
|
BLCA asscociateda
|
52
| |
|
Age (median 71)
|
|
≤ 71 years
|
27
|
51.9
|
|
> 71 years
|
25
|
48.1
|
|
Gender
|
|
Male
|
42
|
80.8
|
|
Female
|
10
|
19.2
|
|
Histological tumor gradeb
|
|
Low grade
|
19
|
36.5
|
|
High grade
|
30
|
57.7
|
|
NA
|
3
|
5.8
|
|
Tumor stageb
|
|
pTa
|
21
|
40.4
|
|
pTis
|
3
|
5.8
|
|
pT1
|
11
|
21.2
|
|
pT2
|
8
|
15.4
|
|
pT3
|
7
|
13.5
|
|
pT4
|
2
|
3.8
|
- aOnly urine samples of patients preoperatively diagnosed with primary bladder cancer (UC, without any other malignancy) were included
- bAccording to WHO 2004 classification
